Analysis

← All Stories

Analysis

Eli Lilly's $4 Billion Vaccine Acquisition: A Strategic Shift in the Pharmaceutical Landscape

Eli Lilly's recent $4 billion acquisition marks a significant strategic shift towards infectious disease prevention, diversifying its revenu…

May 26, 2026
Analysis

Global-e's Strategic Acquisition of Passport: Enhancing E-Commerce Logistics

Global-e enhances its logistics capabilities with the acquisition of Passport, aiming to transform the e-commerce landscape.

May 26, 2026
Analysis

Skyworks Swaps 92% of Qorvo's $1.55B Notes as Qorvo Deal Closes Oct. 5

Skyworks' May 20, 2026 exchange offers for Qorvo's 2029 and 2031 notes settled on October 7, 2026, with about 92% of the $1.55 billion swapp…

May 21, 2026
Analysis

Cycurion's Acquisition of Halo Privacy: Strengthening Government Cybersecurity

Cycurion's acquisition of Halo Privacy bolsters its cybersecurity offerings, positioning it well in a growing market.

May 20, 2026
Analysis

Pennant Buys 40-Unit Tucson Memory Care Site: Deal Math and PNTG Since

On May 18, 2026, Pennant Group bought the real estate and operations of Copper Canyon Memory Care, a 40-unit community in Tucson, Arizona. I…

May 19, 2026
Analysis

Lexitas Pharma Services Expands with Erie Retina Research Acquisition

Lexitas Pharma Services enhances its capabilities by acquiring Erie Retina Research, signaling growth in ophthalmology clinical trials.

May 19, 2026
Analysis

TWO Board's Firm Rejection of UWMC's Acquisition Proposal: Implications for Investors

The TWO board's rejection of UWMC's proposal raises questions about future market dynamics and investor sentiment in mortgage REITs.

May 13, 2026
Analysis

Wendy's Potential Take-Private Deal: What Investors Need to Know

A closer look at Wendy's potential take-private deal and its implications for investors in the restaurant sector.

May 12, 2026